OQROGet OQRO Pro
Insider trade

Disc Medicine (IRON)Director sold ~$140K

Kevin Bitterman, Director at Disc Medicine, sold ~$140K of Disc Medicine shares.

~$140K
Approx. value · 2,287 sh @ $61.03
591K
Holds after · shares reported
Traded
Aug 22, 2025
Filed
Aug 26, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 3, 2025InsiderCEO sold ~$286K of IRON shares in the open market
  2. Jul 9, 2025Insider · 1 personInsiders: 2 sales (~$1.9M)
  3. Jul 10, 2025InsiderCFO sold ~$115K of IRON shares in the open market
  4. Jul 17, 2025InsiderCFO sold ~$120K of IRON shares in the open market
  5. Jul 18, 2025InsiderDirector sold ~$41K of IRON shares in the open market
  6. Jul 23, 2025InsiderDirector sold ~$1.82M of IRON shares in the open market
  7. Jul 24, 2025InsiderDirector sold ~$797K of IRON shares in the open market
  8. Jul 30, 2025InsiderDirector sold ~$518K of IRON shares in the open market
  9. Aug 5, 2025InsiderDirector sold ~$24K of IRON shares in the open market
  10. Aug 13, 2025InsiderDirector sold ~$1.53M of IRON shares in the open market
  11. Aug 14, 2025InsiderDirector sold ~$440K of IRON shares in the open market
  12. Aug 22, 2025 · this disclosureInsiderDirector sold ~$140K of IRON shares in the open market

What came next

  1. Oct 3, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 3, 2025, Mona Ashiya, Ph.D., a Class I member of the Board of Directors (the “Board”) of Disc Medicine, Inc. (the “Company”), notified the Company of her resignation from the Board, effective October 3, 2025.”
  2. Oct 20, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
  3. Oct 20, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  4. Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Disc Medicine

For Disc Medicine, OQRO holds 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IRON page.

Other recent filings by Kevin Bitterman, Director

The full history of Kevin Bitterman, Director is on the profile page.

How this filing works

Other disclosures at Disc Medicine

Everything OQRO holds on this company is on its IRON page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data